{"id":"https://openalex.org/W3214765688","doi":"https://doi.org/10.1093/neuonc/noab196.828","title":"TAMI-45. MICROGLIAL CYTOKINES INDUCE INVASIVENESS AND PROLIFERATION THROUGH PYK2 AND FAK ACTIVATION IN HUMAN GLIOBLASTOMA CELL","display_name":"TAMI-45. MICROGLIAL CYTOKINES INDUCE INVASIVENESS AND PROLIFERATION THROUGH PYK2 AND FAK ACTIVATION IN HUMAN GLIOBLASTOMA CELL","publication_year":2021,"publication_date":"2021-11-02","ids":{"openalex":"https://openalex.org/W3214765688","doi":"https://doi.org/10.1093/neuonc/noab196.828","mag":"3214765688"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noab196.828","doi":"https://doi.org/10.1093/neuonc/noab196.828","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noab196.828","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/23/Supplement_6/vi207/41141572/noab196.828.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/23/Supplement_6/vi207/41141572/noab196.828.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031078707","display_name":"Rebeca E. Nu\u00f1ez","orcid":"https://orcid.org/0000-0001-5731-6506","observed_orcids":["https://orcid.org/0000-0001-5731-6506"]},"institutions":[{"id":"https://openalex.org/I201879955","display_name":"Central University of the Caribbean","ror":"https://ror.org/01rpmzy83","country_code":"PR","type":"education","lineage":["https://openalex.org/I201879955"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Rebeca Nunez","raw_affiliation_strings":["Universidad Central del Caribe, Bayamon, PR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad Central del Caribe, Bayamon, PR, USA","institution_ids":["https://openalex.org/I201879955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083705557","display_name":"Miguel Mayol del Valle","orcid":"https://orcid.org/0000-0002-3269-3994","observed_orcids":["https://orcid.org/0000-0002-3269-3994"]},"institutions":[{"id":"https://openalex.org/I158818660","display_name":"University of Puerto Rico, Medical Sciences Campus","ror":"https://ror.org/00h25w961","country_code":"PR","type":"education","lineage":["https://openalex.org/I158818660","https://openalex.org/I200399037"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Miguel Mayol-Del Valle","raw_affiliation_strings":["University of Puerto Rico, Medical Sciences Campus, San Juan, PR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Puerto Rico, Medical Sciences Campus, San Juan, PR, USA","institution_ids":["https://openalex.org/I158818660"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059423301","display_name":"Luis Almodovar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luis Almodovar","raw_affiliation_strings":["HIMA San Pablo Hospital, Caguas, PR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIMA San Pablo Hospital, Caguas, PR, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026515370","display_name":"Lilia Y. Kucheryavykh","orcid":"https://orcid.org/0000-0001-8053-5619","observed_orcids":["https://orcid.org/0000-0001-8053-5619"]},"institutions":[{"id":"https://openalex.org/I201879955","display_name":"Central University of the Caribbean","ror":"https://ror.org/01rpmzy83","country_code":"PR","type":"education","lineage":["https://openalex.org/I201879955"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Lilia Kucheryavykh","raw_affiliation_strings":["Universidad Central del Caribe, Bayamon, PR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad Central del Caribe, Bayamon, PR, USA","institution_ids":["https://openalex.org/I201879955"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4326,"currency":"USD","value_usd":4326},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.20079163,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"Supplement_6","first_page":"vi207","last_page":"vi208"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9057999849319458,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9057999849319458,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.07800000160932541,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9890000224113464},{"id":"https://openalex.org/keywords/microglia","display_name":"microglia","score":0.796999990940094},{"id":"https://openalex.org/keywords/pyk2","display_name":"Pyk2","score":0.8330000042915344},{"id":"https://openalex.org/keywords/focal-adhesion-kinase","display_name":"focal adhesion kinase","score":0.9900000095367432},{"id":"https://openalex.org/keywords/glioma-invasion","display_name":"glioma invasion","score":0.7269999980926514},{"id":"https://openalex.org/keywords/glioma-cell-proliferation","display_name":"glioma cell proliferation","score":0.8460000157356262},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.7400000095367432},{"id":"https://openalex.org/keywords/epidermal-growth-factor","display_name":"epidermal growth factor","score":0.9580000042915344},{"id":"https://openalex.org/keywords/invadopodia","display_name":"invadopodia","score":0.9240000247955322},{"id":"https://openalex.org/keywords/matrix-degradation","display_name":"matrix degradation","score":0.9070000052452087},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.7379999756813049},{"id":"https://openalex.org/keywords/tocilizumab","display_name":"tocilizumab","score":0.9750000238418579},{"id":"https://openalex.org/keywords/sirna-knockdown","display_name":"siRNA knockdown","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C2779830541","wikidata":"https://www.wikidata.org/wiki/Q1622829","display_name":"Microglia","level":3,"score":0.6925755739212036},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.6807648539543152},{"id":"https://openalex.org/C151166631","wikidata":"https://www.wikidata.org/wiki/Q904514","display_name":"Focal adhesion","level":3,"score":0.6644212007522583},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5723645091056824},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.518501877784729},{"id":"https://openalex.org/C137738243","wikidata":"https://www.wikidata.org/wiki/Q189092","display_name":"Cell migration","level":3,"score":0.4746675491333008},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4675504267215729},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.43121668696403503},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4214818477630615},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.39643505215644836},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.37933212518692017},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2735387682914734},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/neuonc/noab196.828","doi":"https://doi.org/10.1093/neuonc/noab196.828","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noab196.828","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/23/Supplement_6/vi207/41141572/noab196.828.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noab196.828","doi":"https://doi.org/10.1093/neuonc/noab196.828","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noab196.828","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/23/Supplement_6/vi207/41141572/noab196.828.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3214765688.pdf","grobid_xml":"https://content.openalex.org/works/W3214765688.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4200448098","https://openalex.org/W1558070423","https://openalex.org/W7099393255","https://openalex.org/W2312669002","https://openalex.org/W2318520024","https://openalex.org/W2741849925","https://openalex.org/W7098670786","https://openalex.org/W4309015908","https://openalex.org/W7096855792","https://openalex.org/W4386284263"],"abstract_inverted_index":{"Abstract":[0],"Glioblastoma":[1],"(GBM)":[2],"is":[3],"the":[4,31,66,88,242],"most":[5],"aggressive":[6],"and":[7,25,71,95,97,106,127,132,134,148,168,195,204,227,235,250,265,270,277],"highly":[8],"invasive":[9],"primary":[10,157],"brain":[11],"tumor":[12],"in":[13,40,59,92,100,129,137,145,156,172,207,252,267,291],"adults.":[14],"Evidence":[15],"suggests":[16],"that":[17],"microglia":[18,94,179],"create":[19],"a":[20,50,55,114,260],"microenvironment":[21],"favoring":[22],"glioma":[23,41,60,101,138,173,209,247,273],"invasion":[24,61,147,251,271],"proliferation.":[26,43],"Indeed,":[27,229],"previous":[28],"reports":[29],"indicate":[30],"involvement":[32],"of":[33,53,57,118,143,166,202,244,263,272,284],"focal":[34],"adhesion":[35],"kinase":[36],"(FAK)":[37],"signaling":[38,73],"cascades":[39],"cell":[42,102,139,146,158,210,225,248,254],"Besides,":[44],"studies":[45],"from":[46,160],"our":[47],"laboratory":[48],"support":[49,259],"critical":[51],"role":[52,142,262],"Pyk2,":[54],"relative":[56],"FAK,":[58],"by":[62,104,150],"tumor-infiltrating":[63],"microglia.":[64],"However,":[65],"microglial-released":[67],"factors":[68,201],"modulating":[69],"Pyk2":[70,98,264],"FAK":[72,96,266],"pathways":[74],"are":[75],"unknown.":[76],"In":[77],"this":[78],"study,":[79],"20":[80],"human":[81],"GBM":[82,292],"specimens":[83],"were":[84,218],"evaluated":[85],"to":[86,184],"identify":[87],"cytokine":[89],"expression":[90,120],"patterns":[91],"purified":[93],"phosphorylation":[99],"fraction":[103],"RT-PCR":[105],"western":[107],"blot.":[108],"A":[109],"Pierson":[110],"correlation":[111,116],"test":[112],"demonstrated":[113],"high":[115],"(0.8-1.0)":[117],"gene":[119],"for":[121,220,287],"PDGF\u03b1,":[122],"PDGF\u03b2,":[123],"SDF-1\u03b1,":[124],"IL-6,":[125],"IL-8,":[126],"EGF":[128,196],"percoll-purified":[130],"microglia,":[131],"pPyk2(Y579/580)":[133],"pFAK(Y925)":[135],"levels":[136],"fraction.":[140],"The":[141,280],"cytokines":[144],"proliferation":[149,249,269],"Pyk2/FAK":[151],"activation":[152,206],"was":[153,170],"further":[154],"investigated":[155],"lines":[159,255],"three":[161],"patients.":[162,293],"Thirty":[163],"percent":[164],"up-regulation":[165],"pPyk2":[167],"pFAK":[169],"detected":[171],"cells":[174],"treated":[175],"(2":[176],"hrs.)":[177],"with":[178,214],"conditioned":[180],"media":[181],"(MCM)":[182],"compared":[183],"control":[185],"cells.":[186],"siPyk2":[187,215],"or":[188,216],"siFAK":[189,217],"knockdown":[190],"identified":[191],"IL-6":[192,276],"(100":[193],"\u03bcM)":[194,198,240],"(1":[197],"as":[199],"key":[200],"Pyk2-":[203],"FAK-dependent":[205],"all":[208,253],"lines.":[211],"Similar":[212],"results":[213],"observed":[219],"matrix":[221],"degradation,":[222],"invadopodia":[223],"formation,":[224],"viability,":[226],"mitosis.":[228],"Tocilizumab":[230],"(IL-6R":[231],"blocker,":[232,238],"100":[233],"ng/mL)":[234],"Gefitinib":[236],"(EGFR":[237],"1":[239],"reversed":[241],"effect":[243],"MCM":[245],"on":[246],"evaluated.":[256],"These":[257],"findings":[258],"pivotal":[261],"enhancing":[268],"tumors":[274],"through":[275],"EGF-dependent":[278],"pathways.":[279],"latter":[281],"could":[282],"be":[283],"clinical":[285],"relevance":[286],"new":[288],"therapeutic":[289],"developments":[290]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2021-12-06T00:00:00"}